Pegbelfermin (BMS‐986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pegbelfermin (BMS‐986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study

Published:2018-12-06 Issue:1 Volume:27 Page:41-49
ISSN:1930-7381
Container-title:Obesity
language:en
Short-container-title:Obesity

Author:

Charles Edgar D.¹^ORCID,Neuschwander‐Tetri Brent A.²,Pablo Frias Juan³,Kundu Sudeep¹,Luo Yi¹,Tirucherai Giridhar S.¹,Christian Rose¹

Affiliation:

1. Bristol‐Myers Squibb Princeton New Jersey USA

2. Department of Internal Medicine, Division of Gastroenterology and Hepatology Saint Louis University, School of Medicine St. Louis Missouri USA

3. National Research Institute Los Angeles California USA

Funder

Bristol-Myers Squibb

Publisher

Wiley

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/oby.22344

Reference42 articles.

1. Trends in Cardiovascular Disease Risk Factors in Individuals With and Without Diabetes Mellitus in the Framingham Heart Study

2. Trends in Prevalence and Control of Diabetes in the United States, 1988–1994 and 1999–2010

3. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

4. A position statement on NAFLD/NASH based on the EASL 2009 special conference

5. FGF-21 as a novel metabolic regulator

Cited by 199 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computer-aided engineering of stabilized fibroblast growth factor 21;Computational and Structural Biotechnology Journal;2024-12

2. Endocrine fibroblast growth factors in domestic animals;Domestic Animal Endocrinology;2024-10

3. Fibroblast growth factor 21;Differentiation;2024-09

4. Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies;Chinese Journal of Natural Medicines;2024-08

5. Housing mice near vs. below thermoneutrality affects drug-induced weight loss but does not improve prediction of efficacy in humans;Cell Reports;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3